Mylan's patent on the purity of isosulfan blue, a drug used by oncologists to map lymphatic drainage, was affirmed by the Federal Circuit earlier this month.

May 30, 2017

Arguments that CHO host cells were considered unsuitable for commercial scale manufacturing unavailing because commercial scale was not a limitation in the claims.

May 16, 2017

Despite carve-out of patented indication, claims of induced patent infringement proceed to trial based on skinny label.

May 08, 2017

Mechanism of Action Claims Rejected based on Definition of "Therapeutically Effective Amount"

May 01, 2017